The lymphatic system and COVID-19 vaccines.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 13 09 2022
accepted: 10 10 2022
entrez: 7 11 2022
pubmed: 8 11 2022
medline: 9 11 2022
Statut: epublish

Résumé

Understanding the precise mechanism of vaccine-induced protection and the immune correlates of protection against coronavirus disease 2019 (COVID-19) is crucially important for developing next-generation vaccines that confer durable and protective immunity against COVID-19. Similar factors are also important for other infectious diseases. Here, I briefly summarize the mechanism of action of the currently used COVID-19 mRNA vaccines from the viewpoint of the function of the lymphatic system.

Identifiants

pubmed: 36341444
doi: 10.3389/fimmu.2022.1041025
pmc: PMC9630830
doi:

Substances chimiques

COVID-19 Vaccines 0
Viral Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1041025

Informations de copyright

Copyright © 2022 Miyasaka.

Déclaration de conflit d'intérêts

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Pediatr Allergy Immunol. 2020 Jul;31(5):565-569
pubmed: 32319118
Vaccines (Basel). 2021 Jan 18;9(1):
pubmed: 33477534
Nature. 2021 Aug;596(7870):109-113
pubmed: 34182569
N Engl J Med. 2022 Mar 31;386(13):1207-1220
pubmed: 35172051
J Immunol. 1998 Dec 1;161(11):5943-51
pubmed: 9834075
Immunity. 2021 Dec 14;54(12):2877-2892.e7
pubmed: 34852217
Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2204336119
pubmed: 35858382
Sci Immunol. 2021 Apr 15;6(58):
pubmed: 33858945
NPJ Vaccines. 2021 Aug 16;6(1):104
pubmed: 34400651
Immunity. 2005 Aug;23(2):165-75
pubmed: 16111635
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1:E52-7
pubmed: 20961306
Cell. 2021 Apr 29;184(9):2372-2383.e9
pubmed: 33743213
Vaccines (Basel). 2021 Aug 03;9(8):
pubmed: 34451973
Lancet. 2022 Mar 5;399(10328):924-944
pubmed: 35202601
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
Nat Biomed Eng. 2019 May;3(5):371-380
pubmed: 30936432
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Sci Transl Med. 2017 Jun 7;9(393):
pubmed: 28592561
Sci Immunol. 2022 Oct 28;7(76):eadd4853
pubmed: 35857583
Lancet Microbe. 2021 Jun;2(6):e240-e249
pubmed: 33778792
Front Immunol. 2021 Dec 22;12:732690
pubmed: 35003058
N Engl J Med. 2022 Sep 15;387(11):1011-1020
pubmed: 36044620
Front Microbiol. 2022 Feb 11;12:812729
pubmed: 35222312
Nat Commun. 2022 Aug 18;13(1):4855
pubmed: 35982045
Mol Ther. 2017 Dec 6;25(12):2635-2647
pubmed: 28958578
Immunity. 2021 Jun 8;54(6):1257-1275.e8
pubmed: 34051148
Radiology. 2022 Oct;305(1):46-53
pubmed: 35471107
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Nat Commun. 2022 Jun 28;13(1):3700
pubmed: 35764637
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Nat Rev Drug Discov. 2021 Nov;20(11):817-838
pubmed: 34433919
Lancet Reg Health Eur. 2021 Nov;10:100208
pubmed: 34514454
Rev Med Virol. 2003 Nov-Dec;13(6):387-98
pubmed: 14625886
Cell. 2021 Jun 24;184(13):3452-3466.e18
pubmed: 34139176
Int Immunol. 2021 Sep 25;33(10):507-513
pubmed: 33569606
Adv Drug Deliv Rev. 2022 Jul;186:114325
pubmed: 35550392
N Engl J Med. 2022 Jul 7;387(1):86-88
pubmed: 35731894
Vaccines (Basel). 2022 May 28;10(6):
pubmed: 35746474
Science. 2022 Aug 19;377(6608):821-822
pubmed: 35981045
Nat Immunol. 2020 Nov;21(11):1336-1345
pubmed: 32887977
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Immunity. 2020 Jun 16;52(6):971-977.e3
pubmed: 32413330
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1854-1863
pubmed: 33774684
Sci Immunol. 2021 Aug 10;6(62):
pubmed: 34376481
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Vaccines (Basel). 2021 Feb 12;9(2):
pubmed: 33673048
Cell. 2022 Feb 17;185(4):603-613.e15
pubmed: 35026152
Nat Commun. 2020 Nov 27;11(1):6044
pubmed: 33247152
Annu Rev Med. 2022 Jan 27;73:17-39
pubmed: 34669432
Nature. 2022 Jul;607(7917):128-134
pubmed: 35447027

Auteurs

Masayuki Miyasaka (M)

Immunology Frontier Research Center, Osaka University, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH